Циркулирующие ДНК-маркеры при мониторинге рака лёгкого: анализ статуса метилирования ретроэлементов LINE-1; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина

Dettagli Bibliografici
Parent link:Перспективы развития фундаментальных наук=Prospects of Fundamental Sciences Development: сборник научных трудов XV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 24-27 апреля 2018 г./ Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой.— , 2018
Т. 4 : Биология и фундаментальная медицина.— 2018.— [С. 155-157]
Autore principale: Умарова Л. А.
Ente Autore: Национальный исследовательский Томский государственный университет (ТГУ)
Altri autori: Пономарева А. А. (научный руководитель), Чердынцева Н. В.
Riassunto:Заглавие с экрана
It is known that the violation of DNA methylation processes is one of the earliest and most common events in malignant tumors. The purpose of this study was to perform a comparative analysis of the methylation level of LINE-1 retroelements in blood cirDNA in patients with lung cancer before treatment and at the stages of dynamic observation after antitumor therapy. The study included 16 patients with non-small cell lung cancer (NSCLC). The material for the study was venous blood, which was taken before the treatment (10-15 days before the start of treatment), 15-30 days after the end of the last course of non-adjuvant chemotherapy and in the postoperative period for 10-15 days. Analysis of the methylation level of LINE-1 element was performed using a quantitative methyl specific PCR .A linear increase in the methylation index of the LINE-1 fragment in response to antitumor therapy was revealed: after chemotherapy, a statistically significant increase in the methylation index was approximately 2-fold (p = 0.04, paired t-test), 1.4 times after operation indicators after chemotherapy (p = 0.134, paired t-test). As a result, after combined treatment, the LINE-1 methylation index in cc-cirDNA increased 3-fold compared to the level before treatment (p = 0.03, paired t-test). The obtained results indicate the prospectivity of the study on extended samples of lung cancer patients with the significance of the LINE-1 methylation index in blood cirDNA for predicting tumor response to treatment, evaluating the effectiveness of therapy and early detection of relapses.
Lingua:russo
Pubblicazione: 2018
Soggetti:
Accesso online:http://earchive.tpu.ru/handle/11683/50919
Natura: Elettronico Capitolo di libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=627681

MARC

LEADER 00000naa2a2200000 4500
001 627681
005 20231101133455.0
035 |a (RuTPU)RU\TPU\conf\27636 
035 |a RU\TPU\conf\27628 
090 |a 627681 
100 |a 20180919d2018 k y0rusy50 ca 
101 0 |a rus  |d eng 
102 |a RU 
105 |a y z 100zy 
135 |a drgn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Циркулирующие ДНК-маркеры при мониторинге рака лёгкого: анализ статуса метилирования ретроэлементов LINE-1  |d Circulating DNA markers in monitoring lung cancer: analysis of LINE-1 retroelement methylation status  |f Л. А. Умарова, А. А. Пономарева  |g науч. рук. Н. В. Чердынцева 
203 |a Текст  |c электронный 
230 |a 1 компьютерный файл (pdf; 176 Kb) 
300 |a Заглавие с экрана 
320 |a [Библиогр.: с. 157 (5 назв.)] 
330 |a It is known that the violation of DNA methylation processes is one of the earliest and most common events in malignant tumors. The purpose of this study was to perform a comparative analysis of the methylation level of LINE-1 retroelements in blood cirDNA in patients with lung cancer before treatment and at the stages of dynamic observation after antitumor therapy. The study included 16 patients with non-small cell lung cancer (NSCLC). The material for the study was venous blood, which was taken before the treatment (10-15 days before the start of treatment), 15-30 days after the end of the last course of non-adjuvant chemotherapy and in the postoperative period for 10-15 days. Analysis of the methylation level of LINE-1 element was performed using a quantitative methyl specific PCR .A linear increase in the methylation index of the LINE-1 fragment in response to antitumor therapy was revealed: after chemotherapy, a statistically significant increase in the methylation index was approximately 2-fold (p = 0.04, paired t-test), 1.4 times after operation indicators after chemotherapy (p = 0.134, paired t-test). As a result, after combined treatment, the LINE-1 methylation index in cc-cirDNA increased 3-fold compared to the level before treatment (p = 0.03, paired t-test). The obtained results indicate the prospectivity of the study on extended samples of lung cancer patients with the significance of the LINE-1 methylation index in blood cirDNA for predicting tumor response to treatment, evaluating the effectiveness of therapy and early detection of relapses. 
461 1 |0 (RuTPU)RU\TPU\conf\26928  |t Перспективы развития фундаментальных наук  |l Prospects of Fundamental Sciences Development  |o сборник научных трудов XV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 24-27 апреля 2018 г.  |o в 7 т.  |f Национальный исследовательский Томский политехнический университет (ТПУ) ; под ред. И. А. Курзиной, Г. А. Вороновой  |d 2018 
463 1 |0 (RuTPU)RU\TPU\conf\26932  |t Т. 4 : Биология и фундаментальная медицина  |v [С. 155-157]  |d 2018 
510 1 |a Circulating DNA markers in monitoring lung cancer: analysis of LINE-1 retroelement methylation status  |z eng 
610 1 |a электронный ресурс 
610 1 |a ДНК 
610 1 |a маркеры 
610 1 |a мониторинг 
610 1 |a метилирование 
610 1 |a рак легких 
610 1 |a онкологические заболевания 
610 1 |a сравнительный анализ 
610 1 |a кровь 
610 1 |a противоопухолевая терапия 
700 1 |a Умарова  |b Л. А. 
701 1 |a Пономарева  |b А. А. 
702 1 |a Чердынцева  |b Н. В.  |4 727 
712 0 2 |a Национальный исследовательский Томский государственный университет (ТГУ)  |c (2009- )  |2 stltpush  |3 (RuTPU)RU\TPU\col\17230 
801 2 |a RU  |b 63413507  |c 20181008  |g RCR 
856 4 |u http://earchive.tpu.ru/handle/11683/50919 
942 |c BK